The Food and Drug Administration (FDA) has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

Hazard ratio for clinical decline in Clinical Dementia Rating-Sum of Boxes was 0.53 for those treated with gantenerumab the longest ...

Evidence insufficient for making recommendation on upper endoscopic screening or gastric cancer/GPMC detection in high-risk patients.

HealthDay News — Exclusive or longer duration of breastfeeding (at least 6 months) is associated with reduced odds of developmental delays, according to a study published online March 24 in JAMA ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for tolebrutinib for the treatment of non-relapsing ...

Apitegromab, a fully human monoclonal antibody, works by selectively binding to the pro- and latent forms of myostatin in order to inhibit myostatin activation.

New cases suggests that other types of ticks, like the black-legged tick and the western black-legged tick, may also cause the condition.

Scientists and physicians discuss the clinical ramifications of the Trump administration’s anti-LGBTQ+ initiatives.